Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...
drugdeliverybusiness16d
Senseonics, Ascensia launch Eversense 365 year-long CGM in the U.S.
Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) ...
Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 ...
Morningstar16d
Eversense 365 Launches in the US: One Year. One CGM.
Eversense 365 Launches in the US: One Year. One CGM. Manage diabetes and not CGM interruptions with the new Eversense 365 CGM system – the only One Year CGM that is designed to help minimize ...
Nasdaq1mon
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use ...
Zacks.com on MSN23d
Senseonics Stock Down Despite New FDA Approval for Eversense 365
Senseonics Holdings, Inc. SENS, along with Ascensia Diabetes Care, announced the receipt of the FDA’s clearance for the ...
HME News14d
Ascensia launches Eversense 365
Ascensia Diabetes Care has launched its Eversense 365 continuous glucose monitoring system, which received clearance from the U.S. Food and Drug Administration in September. “Eversense offers a ...
Nasdaq1mon
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
With a single sensor, the Eversense 365 system provides one year of use, versus 10-14 days with short-term CGM’s for minimal life disruption “Managing diabetes can be stressful and it is ...
Morningstar7d
Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor
Senseonics' Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by ...
Joplin Globe16d
Eversense 365 Launches in the US: One Year. One CGM.
Ascensia Diabetes Care, a global diabetes care company, announces that it is launching the Eversense ® 365 continuous glucose monitoring (CGM) system, the world’s only One Year CGM, to people ...